Health Trials

Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme

ConditionsCervical Cancer ScreeningCervical Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-65
SponsorInternational Agency for Research on Cancer

About this trial

This project looks to improve the return rate of HPV self-sampling (HPVss) as well as the management of women HPVss positive.

Eligibility criteria

Qualifiers

aged 30-65

did not perform a pap smear in the last 4 years

are living in deprived clusters in the Occitanie region.

did not answer to a first "invitation" letter to perform a clinician-collected HPV testing

Disqualifiers

outside the target age group

had a Pap smear in the past 3 years

had hysterectomy including cervix

are pregnant

Trial design

Treatments tested in this trial

  • Decision aid tailored to women with lower educational attainment,accessible via artificial intelligence-based Chatbot platforms

Treatment groups

3,000 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Centre Régional de Coordination des Dépistages des Cancers-Centre d'OccitanieRecruiting11000, CarcassoneFranceFrance

Sponsors and collaborators

International Agency for Research on Cancer

Lead sponsor

National Cancer Institute, France

Collaborator

Université de Bretagne Occidentale, Brest-France

Collaborator

Source ClinicalTrials.gov